Fact sheet for prescribers – New arrangements for eculizumab (Soliris®)

This fact sheet for prescribers explains changes to the way we provide access to eculizumab (Soliris®) for patients with paroxysmal nocturnal haemoglobinuria from 1 March 2022. It outlines what prescribers need to do to transition their patients to the new arrangements.

Downloads

Fact sheet for prescribers – New arrangements for eculizumab (Soliris®)

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Fact sheet
Audience:
Health sector
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.